A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol

OBJECTIVES: To evaluate the plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus (T2DM) and arteriosclerosis obliteran (ASO) when treated with Probucol plus Cilostazol in combination and individually. METHODS: In this open-label study, patients aged 40–75 years were randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiao-Wei, Guo, Xiao-Hui, Xiao, Xin-Hua, Guo, Li-Xin, Lv, Xiao-Feng, Li, Quan-Min, Gao, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2012
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470020/
https://www.ncbi.nlm.nih.gov/pubmed/23097651
http://dx.doi.org/10.3724/SP.J.1263.2012.02143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470020/
https://www.ncbi.nlm.nih.gov/pubmed/23097651
http://dx.doi.org/10.3724/SP.J.1263.2012.02143

Ejemplares similares